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Occupationalcontactdermatitis(OCD)isthemostcommonoccupationalskindiseaseinmanycountries.Wereviewed thecurrent
evidence on how OCD impacts on quality of life (QoL). The three commonly used QoL questionnaires in OCD were the Short-
Form Health Survey (SF-36), the Dermatology Life Quality Index (DLQI), and the Skindex. Despite the availability of a variety
of validated QoL instruments, none of them is speciﬁc to OCD or entirely adequate in capturing the impact of OCD on QoL.
Nonetheless, the results of this paper do suggest a signiﬁcantimpact. Use of QoL measures in clinical settings will provide patients
with an opportunity to express their concerns and assistcliniciansto evaluate the eﬀectiveness of managementbeyond the clinical
outcomes. This paper also highlights the lack of a disease-speciﬁc QOL instrument and the importance of developing a validated
measure to assess QOL in OCD, enabling comparisonacross countries and occupational groups.
1.Introduction
Occupational contact dermatitis (OCD) has been deﬁned as
a pathologic condition of the skin for which occupational
exposure can be shown to be a major cause or contributory
factor [1].OCD is relatively commonand in many countries,
OCD accounts for the majority of cases of occupational
diseases [2]. In Australia, the incidence of OCD as reported
in 2005 was 2.15 per 10,000 full-time workers per year [3]
and internationally, the incidence of OCD ranged from 1.3
to 8.1 per 10,000 full-time workers per year overthe past two
decades [4].
The two most common types of OCD are allergic
contact dermatitis (ACD) and irritant contact dermatitis
(ICD). ACD is a delayed-type immunological reaction in
response to cutaneous contact with an allergen in sensitised
individuals and is diagnosed by patch testing, while ICD
results from direct contact with aggravating factors such as
wet work, soap, solvents, and heat that triggers the release
of inﬂammatory mediators [2]. No routine clinical testing
is available; therefore, the diagnosis is often made by
exclusion of allergy in ICD. In the acute condition, the OCD
may manifest as itching, redness, scaling, vesiculation, and
clustered papulovesicles while ﬁssuring, hyperkeratosis, and
licheniﬁcation occur in the more chronic state [2].
The impact of OCD is often underestimated because
the course of the disease is not life-threatening and minor
degrees of OCD are accepted as “part of the job”. However,
OCD can have profound eﬀects involving the need to
change occupation and take prolonged sick leave, as well
as limiting leisure activities, interfering with the ability to
perform household chores and the necessity to pursue time-
consuming treatment [5]. These all aﬀect the quality of life
(QoL).
The prognosis of OCD is poor with almost half of all
patients having a condition that does not fully resolve and
c o n t i n u e st oh a v ea ni m p a c to nQ o L[ 6, 7]. The aim of this
paper is to evaluate and summarise the current evidence of2 Journal of Allergy
the impact of OCD on QoL and examine the evidenceon the
sensitivity of the current measures of QoL in OCD.
2.Qualityof LifeMeasuresinOCD
Over recent years, much emphasis has been placed on
measuring the impact of skin diseases on QoL [17]. There
has been a change in emphasis away from the traditional
clinician-determined method of assessing OCD severity to
using the patient’s perspective, as assessed by QoL scores
[25].
The use of QoL measures provides patients with an
opportunity to express their concerns and assist clinicians
in their evaluation of the overall eﬀectiveness of manage-
ment [17]. Generic questionnaires are used to estimate
the patient’s general QoL in various clinical settings while
disease-speciﬁc questionnaires concentrate on a particular
disease. Dermatology-speciﬁc questionnaires describe the
eﬀects of particular skin conditions and allow comparison
of the impacts of diﬀerent skin conditions [26]. Table 1
lists some of the many generic [8–16] and dermatology-
speciﬁc [17–24] questionnaires that are commonly used in
dermatology.
The Short FormHealth Survey(SF-36), the most studied
and validated QoL instrument, is the predominantly used
generic instrument in dermatology [27]. It can be used
across diﬀerent study populations, allowing comparison
between diseases [26]. The SF-36 assesses QoL in eight
domains: physical functioning, role limitation as a result
of physical functioning, bodily pain, general health, vitality,
social functioning, role limitation because of emotional
diﬃculties, and mental health, as well as a question about
health transition. Along with the eight domains of the
SF-36, there are also two summary measures of physical
and mental health called the physical component summary
(PCS) score and the mental component summary (MCS)
score. However, the PCS of SF-36 was found to be less
relevant to dermatology patients than the MCS [28]. Other
generic QoL instruments have been used infrequently in
dermatology over the past decade.
Since its development in 1994, the Dermatology Life
Quality Index (DLQI) questionnaire has been used widely in
assessing QoL in patients with a skin disease [18]. It consists
of ten questions exploring the eﬀect of the skin condition on
six domains: symptoms and feelings, daily activities, leisure,
work, personal relationships, and treatment. Compared to
otherdermatology-speciﬁc QoL instruments, it is easy to use
and has fewer questions, which might reduce the number of
missing responses. Although the DLQI has been found to be
a valid measure of QoL in dermatology, it may not be very
sensitive in detecting small impairments [27].
Skindex, another dermatology-speciﬁc instrument, has
alsobeenshowntobevalid,reliable,andresponsiveinassess-
ing QoLin dermatologypatients[21].The Skindexmeasures
QoL primarily in three domains: emotions, symptoms, and
functioning. Diﬀerent versions of Skindex can be used
depending on the clinical setting. However, interpretation of
scores may be diﬃcult as the meaning of the scores is not
well documented [27]. A combination of both generic and
dermatology-speciﬁcQoLinstrumentshasbeensuggestedby
previous reviewers [5, 27] as the best way to fully capture the
eﬀect of dermatological conditions on QoL.
3.CharacteristicsofStudiesonQOL and OCD
We identiﬁed 11 studies that have investigated QoL in OCD
[29–39] and these are summarised in Table 2.T h es t u d y
design and data collection methods varied greatly across
these studies. Seven were follow-up studies [29, 31, 32, 34–
36, 39], of which ﬁve were performed retrospectively [29, 31,
34, 35, 39], while four studies were cross-sectional [30, 33,
37, 38]. The study participants were either recruited from
dermatology clinics [29–33, 35, 39] or national registries
[34, 36–38] and the study samples ranged in size from 36
to 560 people. Although the participants in all studies had a
clinical diagnosis made at ﬁrst contact, in only 8 studies were
further investigations done to conﬁrm the clinical diagnosis
[30–32,34–37,39].Sevenofthe11studiesreviewedreported
t h ep e r c e n t a g eo fp a r t i c i p a n t sw i t ha t o p y ,w i t ht h eﬁ g u r e
ranging from 7.1% to 92.4% of the study participants [30,
31, 34, 35, 37–39]. Fivestudies used the SF-36or part thereof
[29, 33, 37–39], seven used the DLQI [29, 30, 32, 33, 35, 36,
39], and three used the Skindex questionnaire [31, 37, 38].
Eightstudiesusedthecombinationofadermatology-speciﬁc
instrument and either a commonly used generic instrument
or a self-developed questionnaire [29–31, 33, 35, 37–39].
One study used a self-developed descriptive questionnaire as
the only QOL instrument [34].
4.Results
Overall the studies reviewed have shown a reduction in QoL
in patients with OCD (Table 2). The mean overall SF-36
score was reported in two studies [33, 39]. The aggregated
score of the PCS in these studies were 45.3 [33]a n d5 2
[39] while the aggregated MCS scores were 46.4 [33]a n d5 1
[39]. The score of the average overall quality of life for the
general population is 50 [40], thus both physical and mental
components summary scores in patients with OCD were
slightly lower than those found in the general population.
Two other studies reported the individual domain scores
of the SF-36 rather than the summary score [37, 38]. The
vitalitydomainwasthemost aﬀectedorhadthelowestscores
in three studies [37–39] while one study found that role
limitations as a result of physical diﬃculty were the most
aﬀected domain [33].
Of the seven studies that used DLQI to assess QoL, ﬁve
reported an overall mean score [29, 32, 33, 36, 39]. One
study reported a small eﬀect of OCD on QoL [39], three
found amoderateeﬀect[29, 33,36],andonereported a large
eﬀect on QoL [32]. The most aﬀected domains in the DLQI
were symptoms and feelings [29, 30, 33, 36, 39]a n dw o r k
[29, 32, 33, 35]. The large variation may relate to diﬀerent
methodsofpatientselection,suchasfromreferralclinicsand
workplaces, and duration of followup.
Two out of the three studies that used the Skindex
reported the individual domain scores [31, 37]. The domain
with the highest score in the Soder et al. [37]s t u d yw a sJournal of Allergy 3
Table 1: Generic and dermatology-speciﬁc quality of life instruments used in occupational contact dermatitis.
Instrument Number of
questions Domains Scoring
Generic QoL instrument
SF-36 [8–10]3 6
(i) Physical functioning
Each domain is transformed into a score of
0–100. The scores are then summarised
into mental (MCS) and physical
components (PCS). Higher score indicates
less impaired QoL.
(ii) Role limitations due to physical
diﬃculty
(iii) Bodily pain
(iv) General health
(v) Vitality
(vi) Social functioning
(vii) Role limitations due to emotion
(viii) Mental health
(ix) Health transition
NHP [11, 12]3 8
(i) Energy level
Positive responses in a domainare
summed up or weighting items to calculate
a score ranging from 0–100.
(ii) Emotional reactions
(iii) Physical mobility
(iv) Pain
(v) Social isolation
(vi) Sleep
SIP [13] 136
(i) Physical Scores are calculated per scale, domain,
and as an overall score ranging from
0–100.
(ii) Psychosocial
(iii) Independent categories
GHQ [14, 15]2 8
(i) Somaticsymptoms
A total score (range: 0–84) or a domain
score is obtained by summing up each
item.
(ii) Anxiety and insomnia
(iii) Social dysfunction
(iv) Severe depression
DUKE [16] 17 (i) Health
Score from individual item is summed and
transformed to obtain a total score ranging
from 0–100. Higher score indicates less
impairment to QoL.
(ii) Dysfunction
Dermatology-speciﬁc QoL instrument
DLQI [17, 18]1 0
(i) Symptoms and feelings
A total score between 0–30 is obtained by
summing the score of each question.
Lower score indicates less impaired QoL.
(ii) Daily activities
(iii) Leisure
(iv) Work/school
(v) Personal relationships
(vi) Treatment
Skindex [19–21] 16, 17, 29, 61
(i) Emotions Each domain is scored individually with a
possible score ranging from 0–100. Lower
score indicates less impaired QoL.
(ii) Functioning
(iii) Symptoms4 Journal of Allergy
Table 1: Continued.
Instrument Number of
questions Domains Scoring
DSQL [22, 23]5 2
(i) Psychosocial
A summary score was calculated by adding
all raw scores from each item. (ii) Activities
(iii) Symptoms
DQOLS [24] 41
(i) Physical symptoms
The score for each domain is calculated
separately, transformingto a score ranging
from 0–100.
(ii) Daily activities
(iii) Social activities
(iv) Work/school experience
(v) Self perception
(vi) SF-36 vitality subscale
(vii) SF-36 mental health subscale
SF-36: Short-Form Health Survey; NHP: Nottingham Health Proﬁle; SIP: Sickness Impact Proﬁle; WHOQOL: World Health Organisation Quality of Life;
GHQ: General Health Questionnaire; DUKE: Duke Health Proﬁle; DLQI: Dermatology Life Quality Index; DSQL: Dermatology-speciﬁc Quality of Life;
DQOLS: Dermatology Quality of Life Scales.
symptoms (score: 56.9), while Kadyk et al. [31]r e p o r t e d
that the emotions domain had the highest score (score:
33.8)when compared to otherdomains in the questionnaire.
Althoughahigherscoregenerallyindicatesagreatereﬀecton
QoL,thedegreeofimpairmentcouldnotbeestimated dueto
absence of reference values or population norm score [40].
The diﬀerent QoL measures all assess the impact of
disease on various domains including symptoms/feelings,
eﬀect on work, daily activities and functioning,
social/interpersonal activities, and other aspects of QoL. The
eﬀects of OCD on these diﬀerent aspects of quality of life are
summarised in Table 3.
4.1. Symptoms and Feelings. OCD frequently invokes strong
negative emotions such as frustration, embarrassment, and
depression, a reﬂection that the skin is responsible in large
part for an individual’s presentation [41]. These negative
psychosocial eﬀects were strongly associated with a low or
reduced QoL [31, 36]. Symptoms and feelings were the most
aﬀecteddomainsofQoL in nine outofthe11 studies[29, 30,
33–39]. In the DLQI, this domain captures information on
symptoms such as itch, sore/pain and stinging, and feelings
of embarrassment and self-consciousness over the last week.
All three studies that reported individual DLQI domain
scores found a very large impact of OCD on symptoms and
feelings domain [29, 33, 39]. In one of the reviewed studies,
61% of participants complained of symptoms and 36% felt
embarrassed about their OCD [30].
The Skindex assesses the symptoms and feelings in
t w oi n d i v i d u a ld o m a i n s[ 21]. Similar to the DLQI, the
Skindex captures data on itch, stinging or burning, pain and
irritation, as well as emotions like feeling worried, bothered
by appearance, being frustrated, embarrassed, and feeling
depressed about the skin. One study using Skindex found
the symptom domain had the highest reported average score
followed by the emotions domain [37] while another study
found no signiﬁcant diﬀerence in these two domains when
a comparison was made between those with and without
occupational ACD [31].
The mental health domain from the SF-36 corresponds
to the symptoms and feelings domain in the DLQI and
the Skindex. However, its emphasis is more on emotions
rather than symptoms. The mental health domain includes
questions about feeling nervousness, upset, depressed, calm
and peaceful, and happy. The scores were signiﬁcantly
reduced, indicating a negative eﬀect of OCD on mental
health, in three studies using the SF-36 [33, 37, 38].
4.2. Work. The impact of OCD is most frequently reported
intermsofitseﬀectonworkactivities.IntheSF-36,theeﬀect
on work ismeasured bythe domain rolelimitation caused by
physical functioning over the past four weeks. The domain
measures the limitation of performing tasks, such as cutting
down the amount of time spent on work, accomplishing
less work than expected, limitation in the kind of work, and
diﬃculties in performing work. Of the ﬁve studies that used
the SF-36, two reported signiﬁcantly reduced domain scores
when compared to population norms [33, 38] while another
two had no diﬀerence with the population norms scores
[37, 39]. One study did not report the domain score [29]b u t
found that 45% of males accomplished less at work and 40%
of females had diﬃculty in performing work.
Seven studies were using the DLQI which measured the
impact of OCD on work impediment and predicament at
work over the last week. Only three studies reported the
scores [29, 33, 39]. Two found a moderate eﬀect of OCD
on work [29, 39] while one found a very large impact on
work [33].Otherstudiesfoundthat20%oftheirparticipants
could not work [30], 43% had interference with work [30],
and 39% reported severe impact on work [32].
In those with OCD, the proportion that had either
changed job or made job modiﬁcations ranged between
23.1%–82% [34, 35, 37]. An explanation for this large varia-
tion may be due to the variety of occupations represented inJournal of Allergy 5
T
a
b
l
e
2
:
S
t
u
d
y
d
e
s
i
g
n
a
n
d
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
d
i
ﬀ
e
r
e
n
t
s
t
u
d
i
e
s
o
n
O
C
D
.
A
u
t
h
o
r
C
o
u
n
t
r
y
a
n
d
y
e
a
r
S
t
u
d
y
d
e
s
i
g
n
R
e
c
r
u
i
t
m
e
n
t
N
o
.
o
f
p
a
r
t
i
c
i
p
a
n
t
s
(
%
o
f
f
e
m
a
l
e
)
A
t
o
p
y
(
%
)
M
e
a
n
a
g
e
±
s
.
d
.
,
r
a
n
g
e
D
e
ﬁ
n
i
t
i
o
n
o
f
d
i
a
g
n
o
s
i
s
I
n
v
e
s
t
i
g
a
t
i
o
n
s
H
u
t
c
h
i
n
g
s
e
t
a
l
.
[
2
9
]
U
K
,
2
0
0
1
R
e
t
r
o
s
p
e
c
t
i
v
e
f
o
l
l
o
w
u
p
u
s
i
n
g
p
o
s
t
a
l
s
u
r
v
e
y
C
o
n
t
a
c
t
d
e
r
m
a
t
i
t
i
s
c
l
i
n
i
c
1
8
1
(
4
7
.
0
)
N
A
1
8
–
6
7
O
C
D
d
i
a
g
n
o
s
e
d
b
y
p
h
y
s
i
c
i
a
n
a
t
b
a
s
e
l
i
n
e
N
A
H
o
l
n
e
s
s
[
3
0
]
C
a
n
a
d
a
,
2
0
0
1
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
O
c
c
u
p
a
t
i
o
n
a
l
H
e
a
l
t
h
C
l
i
n
i
c
3
3
9
(
5
4
)
5
9
4
2
.
5
C
o
n
t
a
c
t
d
e
r
m
a
t
i
t
i
s
d
i
a
g
n
o
s
e
d
b
y
p
h
y
s
i
c
i
a
n
P
a
t
c
h
-
t
e
s
t
i
n
g
K
a
d
y
k
e
t
a
l
.
[
3
1
]
U
S
A
,
2
0
0
3
R
e
t
r
o
s
p
e
c
t
i
v
e
f
o
l
l
o
w
u
p
b
y
p
o
s
t
a
l
s
u
r
v
e
y
C
o
n
t
a
c
t
d
e
r
m
a
t
i
t
i
s
t
e
s
t
c
e
n
t
r
e
1
4
9
(
6
4
.
5
)
1
1
.
9
5
3
.
0
±
1
6
.
6
A
C
D
d
i
a
g
n
o
s
e
d
b
y
p
h
y
s
i
c
i
a
n
a
t
b
a
s
e
l
i
n
e
P
a
t
c
h
-
t
e
s
t
i
n
g
a
t
b
a
s
e
l
i
n
e
L
e
w
i
s
e
t
a
l
.
[
3
2
]
U
K
,
2
0
0
4
F
o
l
l
o
w
u
p
C
o
n
t
a
c
t
d
e
r
m
a
t
i
t
i
s
c
l
i
n
i
c
3
6
N
A
3
6
(
2
2
–
5
6
)
W
o
r
k
-
r
e
l
a
t
e
d
n
a
t
u
r
a
l
l
a
t
e
x
a
l
l
e
r
g
y
d
i
a
g
n
o
s
e
d
b
y
p
h
y
s
i
c
i
a
n
P
r
i
c
k
t
e
s
t
a
t
b
a
s
e
l
i
n
e
W
a
l
l
e
n
h
a
m
m
a
r
e
t
a
l
.
[
3
3
]
S
w
e
d
e
n
,
2
0
0
4
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
O
c
c
u
p
a
t
i
o
n
a
l
a
n
d
E
n
v
i
r
o
n
m
e
n
t
a
l
D
e
r
m
a
t
o
l
o
g
y
C
l
i
n
i
c
1
0
0
(
5
1
)
N
A
F
e
m
a
l
e
s
4
1
(
2
0
–
6
4
)
,
m
a
l
e
s
4
2
(
1
9
–
6
4
)
H
a
n
d
e
c
z
e
m
a
d
i
a
g
n
o
s
e
d
b
y
p
h
y
s
i
c
i
a
n
N
A
M
e
d
i
n
g
e
t
a
l
.
[
3
4
]
S
w
e
d
e
n
,
2
0
0
5
R
e
t
r
o
s
p
e
c
t
i
v
e
f
o
l
l
o
w
u
p
u
s
i
n
g
p
o
s
t
a
l
a
n
d
t
e
l
e
p
h
o
n
e
s
u
r
v
e
y
C
a
s
e
s
f
r
o
m
s
o
c
i
a
l
i
n
s
u
r
a
n
c
e
o
ﬃ
c
e
5
1
7
(
3
9
4
p
o
s
t
a
l
&
1
2
3
t
e
l
e
p
h
o
n
e
)
(
6
2
.
5
)
2
4
.
5
1
6
–
6
4
O
c
c
u
p
a
t
i
o
n
a
l
s
k
i
n
d
i
s
e
a
s
e
d
i
a
g
n
o
s
e
d
b
y
p
h
y
s
i
c
i
a
n
a
t
b
a
s
e
l
i
n
e
P
a
t
c
h
-
t
e
s
t
i
n
g
a
t
b
a
s
e
l
i
n
e
L
a
z
a
r
o
v
e
t
a
l
.
[
3
5
]
I
s
r
a
e
l
,
2
0
0
6
R
e
t
r
o
s
p
e
c
t
i
v
e
f
o
l
l
o
w
u
p
b
y
t
e
l
e
p
h
o
n
e
s
u
r
v
e
y
C
o
n
t
a
c
t
d
e
r
m
a
t
i
t
i
s
c
l
i
n
i
c
7
0
(
3
5
.
7
)
7
.
1
2
5
–
5
9
O
C
D
d
i
a
g
n
o
s
e
d
b
y
d
e
r
m
a
t
o
l
o
g
i
s
t
a
t
b
a
s
e
l
i
n
e
P
a
t
c
h
-
t
e
s
t
i
n
g
a
t
b
a
s
e
l
i
n
e
C
v
e
t
k
o
v
s
k
i
e
t
a
l
.
[
3
6
]
D
e
n
m
a
r
k
,
2
0
0
6
F
o
l
l
o
w
u
p
b
y
m
a
i
l
1
y
e
a
r
a
f
t
e
r
b
a
s
e
l
i
n
e
q
u
e
s
t
i
o
n
n
a
i
r
e
w
a
s
r
e
t
u
r
n
e
d
D
a
n
i
s
h
N
a
t
i
o
n
a
l
B
o
a
r
d
o
f
I
n
d
u
s
t
r
i
a
l
I
n
j
u
r
i
e
s
(
D
N
B
I
I
)
5
6
4
N
A
3
5
.
8
O
c
c
u
p
a
t
i
o
n
a
l
h
a
n
d
e
c
z
e
m
a
d
i
a
g
n
o
s
e
d
b
y
d
e
r
m
a
t
o
l
o
g
i
s
t
a
t
b
a
s
e
l
i
n
e
P
a
t
c
h
-
t
e
s
t
i
n
g
,
a
d
d
i
t
i
o
n
a
l
p
r
i
c
k
t
e
s
t
w
h
e
n
r
e
l
e
v
a
n
t
S
o
d
e
r
e
t
a
l
.
[
3
7
]
G
e
r
m
a
n
y
,
2
0
0
7
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
C
l
e
a
n
i
n
g
a
n
d
k
i
t
c
h
e
n
e
m
p
l
o
y
e
e
w
h
o
r
e
p
o
r
t
e
d
t
o
B
G
W
2
1
2
(
8
4
.
0
)
4
7
.
2
%
a
t
o
p
i
c
s
k
i
n
d
i
a
t
h
e
s
i
s
,
1
5
.
6
%
ﬂ
e
x
u
r
a
l
e
c
z
e
m
a
4
1
.
6
±
1
0
.
8
E
m
p
l
o
y
e
e
s
s
u
s
p
e
c
t
e
d
w
i
t
h
o
c
c
u
p
a
t
i
o
n
a
l
s
k
i
n
d
i
s
e
a
s
e
A
l
l
e
r
g
y
t
e
s
t
p
r
i
o
r
t
o
s
t
u
d
y6 Journal of Allergy
T
a
b
l
e
2
:
C
o
n
t
i
n
u
e
d
.
A
u
t
h
o
r
C
o
u
n
t
r
y
a
n
d
y
e
a
r
S
t
u
d
y
d
e
s
i
g
n
R
e
c
r
u
i
t
m
e
n
t
N
o
.
o
f
p
a
r
t
i
c
i
p
a
n
t
s
(
%
o
f
f
e
m
a
l
e
)
A
t
o
p
y
(
%
)
M
e
a
n
a
g
e
±
s
.
d
.
,
r
a
n
g
e
D
e
ﬁ
n
i
t
i
o
n
o
f
d
i
a
g
n
o
s
i
s
I
n
v
e
s
t
i
g
a
t
i
o
n
s
M
a
t
t
e
r
n
e
e
t
a
l
.
[
3
8
]
G
e
r
m
a
n
y
,
2
0
0
9
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
H
e
a
l
t
h
c
a
r
e
w
o
r
k
e
r
s
w
h
o
r
e
p
o
r
t
e
d
t
o
B
G
W
2
7
8
(
9
2
.
4
)
5
5
.
4
%
a
t
o
p
y
,
2
3
.
7
%
ﬂ
e
x
u
r
a
l
e
c
z
e
m
a
3
6
.
9
±
1
1
.
6
E
m
p
l
o
y
e
e
s
s
u
s
p
e
c
t
e
d
w
i
t
h
o
c
c
u
p
a
t
i
o
n
a
l
s
k
i
n
d
i
s
e
a
s
e
N
A
L
a
u
e
t
a
l
.
[
3
9
]
A
u
s
t
r
a
l
i
a
,
2
0
1
0
I
n
t
e
r
v
i
e
w
e
r
-
a
d
m
i
n
i
s
t
e
r
e
d
r
e
t
r
o
s
p
e
c
t
i
v
e
f
o
l
l
o
w
u
p
O
c
c
u
p
a
t
i
o
n
a
l
d
e
r
m
a
t
o
l
o
g
y
c
l
i
n
i
c
1
1
3
(
4
7
.
8
)
4
8
.
7
4
1
.
2
±
1
3
.
4
O
C
D
d
i
a
g
n
o
s
e
d
b
y
d
e
r
m
a
t
o
l
o
g
i
s
t
a
t
b
a
s
e
l
i
n
e
a
n
d
a
t
f
o
l
l
o
w
u
p
P
a
t
c
h
t
e
s
t
i
n
g
a
t
b
a
s
e
l
i
n
e
N
A
:
i
n
f
o
r
m
a
t
i
o
n
n
o
t
a
v
a
i
l
a
b
l
e
/
n
o
t
p
e
r
f
o
r
m
e
d
,
S
I
P
:
s
e
c
o
n
d
a
r
y
i
n
d
i
v
i
d
u
a
l
p
r
e
v
e
n
t
i
o
n
,
B
G
W
:
A
c
c
i
d
e
n
t
P
r
e
v
e
n
t
i
o
n
a
n
d
I
n
s
u
r
a
n
c
e
A
s
s
o
c
i
a
t
i
o
n
.Journal of Allergy 7
T
a
b
l
e
3
:
E
ﬀ
e
c
t
s
o
f
o
c
c
u
p
a
t
i
o
n
a
l
c
o
n
t
a
c
t
d
e
r
m
a
t
i
t
i
s
o
n
d
i
ﬀ
e
r
e
n
t
a
s
p
e
c
t
s
o
f
q
u
a
l
i
t
y
o
f
l
i
f
e
.
A
u
t
h
o
r
Q
u
e
s
t
i
o
n
n
a
i
r
e
(
s
)
u
s
e
d
M
e
a
n
s
c
o
r
e
S
e
v
e
r
i
t
y
a
s
s
e
s
s
m
e
n
t
O
v
e
r
a
l
l
e
ﬀ
e
c
t
o
n
g
e
n
d
e
r
S
y
m
p
t
o
m
s
/
f
e
e
l
i
n
g
s
W
o
r
k
D
a
i
l
y
a
c
t
i
v
i
t
i
e
s
/
f
u
n
c
t
i
o
n
i
n
g
S
o
c
i
a
l
/
i
n
t
e
r
p
e
r
s
o
n
a
l
a
c
t
i
v
i
t
i
e
s
O
t
h
e
r
s
H
u
t
c
h
i
n
g
s
e
t
a
l
.
[
2
9
]
D
L
Q
I
,
p
a
r
t
o
f
S
F
-
3
6
D
L
Q
I
6
.
6
;
S
F
-
3
6
N
A
N
A
N
o
d
i
ﬀ
e
r
e
n
c
e
M
o
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
w
i
t
h
h
i
g
h
e
r
e
ﬀ
e
c
t
o
n
f
e
m
a
l
e
A
ﬀ
e
c
t
e
d
b
u
t
n
o
t
p
r
e
v
e
n
t
e
d
w
i
t
h
h
i
g
h
e
r
e
ﬀ
e
c
t
o
n
m
a
l
e
s
N
A
L
e
a
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
H
o
l
n
e
s
s
[
3
0
]
M
o
d
i
ﬁ
e
d
D
L
Q
I
,
o
p
e
n
-
e
n
d
e
d
q
u
e
s
t
i
o
n
s
D
L
Q
I
N
A
N
A
N
A
6
1
%
c
o
m
p
l
a
i
n
e
d
o
f
i
t
c
h
i
n
e
s
s
/
p
a
i
n
,
3
6
%
f
e
l
t
e
m
b
a
r
r
a
s
s
e
d
2
0
%
c
o
u
l
d
n
o
t
w
o
r
k
a
n
d
4
3
%
h
a
d
i
n
t
e
r
f
e
r
e
n
c
e
w
i
t
h
w
o
r
k
3
2
%
h
a
d
s
l
e
e
p
d
i
s
t
u
r
b
a
n
c
e
,
2
3
%
h
a
d
i
n
t
e
r
f
e
r
e
n
c
e
w
i
t
h
h
o
u
s
e
w
o
r
k
/
s
h
o
p
p
i
n
g
2
0
%
w
e
r
e
a
ﬀ
e
c
t
e
d
T
h
o
s
e
w
i
t
h
h
a
n
d
i
n
v
o
l
v
e
m
e
n
t
r
e
p
o
r
t
e
d
a
w
o
r
s
e
Q
o
L
.
K
a
d
y
k
e
t
a
l
.
[
3
1
]
S
k
i
n
d
e
x
-
1
6
,
a
d
d
i
t
i
o
n
a
l
q
u
e
s
t
i
o
n
s
o
n
o
c
c
u
p
a
t
i
o
n
a
l
i
m
p
a
c
t
S
k
i
n
d
e
x
-
1
6
i
n
d
i
v
i
d
u
a
l
s
c
a
l
e
r
a
n
g
e
s
f
r
o
m
1
3
.
3
–
3
1
.
0
N
A
N
A
N
A
S
i
g
n
i
ﬁ
c
a
n
t
l
y
m
o
r
e
a
ﬀ
e
c
t
e
d
c
o
m
p
a
r
e
d
t
o
t
h
o
s
e
w
i
t
h
n
o
n
o
c
c
u
p
a
t
i
o
n
a
l
A
C
D
S
l
i
g
h
t
l
y
m
o
r
e
i
m
p
a
i
r
e
d
t
h
a
n
t
h
o
s
e
w
i
t
h
n
o
n
o
c
c
u
p
a
t
i
o
n
a
l
A
C
D
C
o
n
c
e
r
n
e
d
t
h
a
t
i
n
t
e
r
a
c
t
i
o
n
w
i
t
h
c
o
w
o
r
k
e
r
s
m
a
y
b
e
d
i
ﬃ
c
u
l
t
L
e
w
i
s
e
t
a
l
.
[
3
2
]
D
L
Q
I
B
e
f
o
r
e
d
i
a
g
n
o
s
i
s
1
7
.
9
;
a
f
t
e
r
d
i
a
g
n
o
s
i
s
1
0
.
9
N
A
N
A
N
A
3
9
%
r
e
p
o
r
t
e
d
s
e
v
e
r
e
i
m
p
a
c
t
o
n
w
o
r
k
N
A
4
4
%
h
a
d
i
s
s
u
e
s
w
i
t
h
i
n
t
e
r
p
e
r
s
o
n
a
l
r
e
l
a
t
i
o
n
s
h
i
p
s
W
a
l
l
e
n
h
a
m
m
a
r
e
t
a
l
.
[
3
3
]
D
L
Q
I
,
S
F
-
3
6
D
L
Q
I
7
.
4
;
S
F
-
3
6
P
C
S
4
5
.
3
;
M
C
S
4
6
.
4
N
A
N
o
d
i
ﬀ
e
r
e
n
c
e
o
n
D
L
Q
I
;
f
e
m
a
l
e
h
a
d
m
o
r
e
i
m
p
a
i
r
e
d
Q
o
L
o
n
S
F
-
3
6
V
e
r
y
l
a
r
g
e
e
ﬀ
e
c
t
M
o
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
i
n
D
L
Q
I
,
s
i
g
n
i
ﬁ
c
a
n
t
l
y
r
e
d
u
c
e
d
r
o
l
e
-
p
h
y
s
i
c
a
l
d
o
m
a
i
n
i
n
S
F
-
3
6
2
3
%
f
e
m
a
l
e
s
a
n
d
1
8
%
m
a
l
e
s
r
e
p
o
r
t
e
d
i
n
t
e
r
f
e
r
e
n
c
e
w
i
t
h
d
a
i
l
y
a
c
t
i
v
i
t
i
e
s
P
e
r
s
o
n
a
l
r
e
l
a
t
i
o
n
s
h
i
p
w
a
s
t
h
e
l
e
a
s
t
e
ﬀ
e
c
t
e
d
M
e
d
i
n
g
e
t
a
l
.
[
3
4
]
S
e
l
f
-
d
e
v
e
l
o
p
e
d
q
u
e
s
t
i
o
n
n
a
i
r
e
s
N
A
N
A
N
A
5
2
%
h
a
d
s
y
m
p
t
o
m
s
>
h
a
l
f
o
f
t
h
e
t
i
m
e
;
f
e
m
a
l
e
s
m
o
r
e
a
ﬀ
e
c
t
e
d
,
8
0
%
r
e
p
o
r
t
e
d
i
t
c
h
i
n
g
t
o
t
h
e
i
r
h
a
n
d
e
c
z
e
m
a
8
2
%
c
h
a
n
g
e
d
w
o
r
k
s
i
t
u
a
t
i
o
n
,
4
4
%
c
h
a
n
g
e
d
j
o
b
N
A
8
8
%
r
e
p
o
r
t
e
d
e
ﬀ
e
c
t
o
n
p
s
y
c
h
o
s
o
c
i
a
l
a
n
d
h
a
d
t
o
g
i
v
e
u
p
o
n
t
h
e
i
r
h
o
b
b
i
e
s
2
8
%
h
a
d
t
o
t
a
l
r
e
c
o
v
e
r
y
L
a
z
a
r
o
v
e
t
a
l
.
[
3
5
]
D
L
Q
I
,
s
e
l
f
-
d
e
v
e
l
o
p
e
d
q
u
e
s
t
i
o
n
n
a
i
r
e
s
D
L
Q
I
N
A
N
I
I
-
r
a
t
e
d
N
A
4
5
.
7
%
f
e
e
l
i
n
g
s
h
a
m
e
a
n
d
r
e
j
e
c
t
e
d
5
2
.
9
%
c
h
a
n
g
e
d
j
o
b
4
5
.
7
%
r
e
p
o
r
t
e
d
i
n
t
e
r
f
e
r
e
n
c
e
1
8
.
6
%
h
a
d
l
i
m
i
t
a
t
i
o
n
s
i
n
i
n
t
e
r
p
e
r
s
o
n
a
l
r
e
l
a
t
i
o
n
s
h
i
p
1
1
.
4
%
h
a
d
p
e
r
s
i
s
t
e
n
t
d
e
r
m
a
t
i
t
i
s8 Journal of Allergy
T
a
b
l
e
3
:
C
o
n
t
i
n
u
e
d
.
A
u
t
h
o
r
Q
u
e
s
t
i
o
n
n
a
i
r
e
(
s
)
u
s
e
d
M
e
a
n
s
c
o
r
e
S
e
v
e
r
i
t
y
a
s
s
e
s
s
m
e
n
t
O
v
e
r
a
l
l
e
ﬀ
e
c
t
o
n
g
e
n
d
e
r
S
y
m
p
t
o
m
s
/
f
e
e
l
i
n
g
s
W
o
r
k
D
a
i
l
y
a
c
t
i
v
i
t
i
e
s
/
f
u
n
c
t
i
o
n
i
n
g
S
o
c
i
a
l
/
i
n
t
e
r
p
e
r
s
o
n
a
l
a
c
t
i
v
i
t
i
e
s
O
t
h
e
r
s
C
v
e
t
k
o
v
s
k
i
e
t
a
l
.
[
3
6
]
D
L
Q
I
,
B
D
I
-
I
I
D
L
Q
I
5
.
5
;
B
D
I
-
I
I
7
.
1
D
N
B
I
I
-
r
a
t
e
d
N
o
d
i
ﬀ
e
r
e
n
c
e
M
o
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
,
9
%
r
e
p
o
r
t
e
d
m
o
d
e
r
a
t
e
-
t
o
-
s
e
v
e
r
e
d
e
p
r
e
s
s
i
o
n
a
t
b
a
s
e
l
i
n
e
a
n
d
a
t
f
o
l
l
o
w
u
p
M
o
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
a
t
b
a
s
e
l
i
n
e
N
A
N
A
S
t
r
o
n
g
a
s
s
o
c
i
a
t
i
o
n
b
e
t
w
e
e
n
m
i
l
d
-
t
o
-
m
o
d
e
r
a
t
e
O
H
E
a
n
d
s
e
v
e
r
e
O
H
E
a
n
d
l
o
w
Q
o
L
a
t
b
a
s
e
l
i
n
e
S
o
d
e
r
e
t
a
l
.
[
3
7
]
S
F
-
3
6
,
S
k
i
n
d
e
x
-
2
9
S
F
-
3
6
i
n
d
i
v
i
d
u
a
l
s
c
a
l
e
r
a
n
g
e
s
f
r
o
m
5
3
.
9
–
8
1
.
4
;
S
k
i
n
d
e
x
-
2
9
i
n
d
i
v
i
d
u
a
l
s
c
o
r
e
r
a
n
g
e
2
3
.
0
–
5
6
.
9
P
h
y
s
i
c
i
a
n
-
a
s
s
e
s
s
e
d
F
e
m
a
l
e
s
m
o
r
e
a
ﬀ
e
c
t
e
d
i
n
m
o
s
t
s
u
b
s
c
a
l
e
s
o
f
S
F
-
3
6
M
o
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
w
i
t
h
1
2
.
7
%
r
e
p
o
r
t
e
d
i
t
c
h
i
n
e
s
s
o
n
e
n
t
i
r
e
s
k
i
n
s
u
r
f
a
c
e
&
3
7
.
7
%
o
n
h
a
n
d
s
3
1
.
1
%
h
a
d
<
8
w
e
e
k
s
o
f
s
i
c
k
l
e
a
v
e
;
4
8
.
6
%
w
e
r
e
a
b
s
e
n
t
f
r
o
m
w
o
r
k
.
2
3
.
1
%
f
r
o
m
t
e
l
e
p
h
o
n
e
s
u
r
v
e
y
c
h
a
n
g
e
d
o
r
g
a
v
e
u
p
t
h
e
i
r
p
r
o
f
e
s
s
i
o
n
L
e
a
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
i
n
S
k
i
n
d
e
x
N
A
N
o
s
i
g
n
i
ﬁ
c
a
n
t
c
o
r
r
e
l
a
t
i
o
n
b
e
t
w
e
e
n
s
e
v
e
r
i
t
y
o
f
s
k
i
n
a
n
d
Q
o
L
.
6
5
%
f
r
o
m
t
e
l
e
p
h
o
n
e
s
u
r
v
e
y
h
a
d
i
m
p
r
o
v
e
d
s
k
i
n
M
a
t
t
e
r
n
e
e
t
a
l
.
[
3
8
]
S
F
-
3
6
,
S
k
i
n
d
e
x
-
2
9
S
F
-
3
6
i
n
d
i
v
i
d
u
a
l
s
c
a
l
e
r
a
n
g
e
s
f
r
o
m
5
4
.
2
–
8
9
.
6
;
S
k
i
n
d
e
x
-
2
9
r
a
w
s
c
o
r
e
N
A
Y
e
s
N
o
d
i
ﬀ
e
r
e
n
c
e
o
n
S
F
-
3
6
,
f
e
m
a
l
e
s
m
o
r
e
a
ﬀ
e
c
t
e
d
o
n
S
k
i
n
d
e
x
-
2
9
F
e
m
a
l
e
s
r
e
p
o
r
t
e
d
m
o
r
e
e
m
o
t
i
o
n
a
l
i
m
p
a
i
r
m
e
n
t
,
m
o
r
e
i
m
p
a
i
r
e
d
s
o
c
i
a
l
f
u
n
c
t
i
o
n
i
n
g
a
n
d
m
e
n
t
a
l
h
e
a
l
t
h
N
A
L
e
s
s
i
m
p
a
i
r
e
d
p
h
y
s
i
c
a
l
f
u
n
c
t
i
o
n
i
n
g
c
o
m
p
a
r
e
d
t
o
g
e
n
e
r
a
l
p
o
p
u
l
a
t
i
o
n
N
A
M
o
r
e
s
e
v
e
r
e
s
k
i
n
i
s
a
s
s
o
c
i
a
t
e
d
w
i
t
h
p
e
r
c
e
i
v
e
d
p
a
i
n
L
a
u
e
t
a
l
.
[
3
9
]
D
L
Q
I
,
S
F
-
3
6
D
L
Q
I
4
.
5
;
S
F
-
3
6
P
C
S
5
2
;
M
C
S
5
1
P
h
y
s
i
c
i
a
n
-
r
a
t
e
d
,
p
a
t
i
e
n
t
-
r
a
t
e
d
,
O
D
D
I
N
o
d
i
ﬀ
e
r
e
n
c
e
M
o
s
t
a
ﬀ
e
c
t
e
d
d
o
m
a
i
n
i
n
D
L
Q
I
,
l
o
w
e
r
m
e
n
t
a
l
h
e
a
l
t
h
s
c
o
r
e
s
V
e
r
y
l
a
r
g
e
e
ﬀ
e
c
t
M
o
d
e
r
a
t
e
l
y
a
ﬀ
e
c
t
e
d
a
s
m
e
a
s
u
r
e
d
b
y
D
L
Q
I
,
n
o
e
ﬀ
e
c
t
i
n
S
F
-
3
6
d
o
m
a
i
n
s
N
o
e
ﬀ
e
c
t
o
n
s
o
c
i
a
l
f
u
n
c
t
i
o
n
i
n
g
S
i
g
n
i
ﬁ
c
a
n
t
c
o
r
r
e
l
a
t
i
o
n
b
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this paper or due to diﬀerences in disease duration between
studies.Thehigh proportionofpeoplewith jobmodiﬁcation
in the study by Meding et al. [34] might have been due
to the use of nonstandardised questions compared to other
validated instruments.
4.3. Daily Activities/Physical Functioning. Six studies docu-
mented the eﬀect of OCD on daily activities or physical
functioning using the DLQI, Skindex, and/or the SF-36.
The SF-36 has ten questions about the impact on daily
physical functioning such as bathing or dressing, walk-
ing, and climbing stairs. When the domain scores were
compared to the general population scores, one study
found a signiﬁcant impairment in the physical functioning
domain [33], whereas in two other studies, the authors
found no eﬀect on physical functioning in OCD patients
[38, 39].
The daily activities domain is assessed by two questions
in the DLQI: interference with housework, shopping or
gardening, and inﬂuence to the choice of clothing over the
last week. Two studies using the DLQI, found a moderate
eﬀect on the daily activities domain [33, 39]. Two other
studies that used the DLQI but did not document the scores
reported that 23% [30] and 45.7% [35]o fp a r t i c i p a n t s
had interference in this domain. Holness [30]r e p l a c e do n e
questionfromtheDLQIwithonerelatedtosleepdisturbance
and 44% of patients reported an eﬀect of OCD on sleep. A
similar impact on daily activities was reported by Kadyk et
al. [31], who found that OCD had a signiﬁcant impact on
daily activities in those with occupational ACD compared
to ACD that was not occupational. This study used the
Skindex questionnaire which did not further deﬁne daily
activities. Although most studies reported interference with
daily activities or physical functioning, it was often the least
aﬀected domain.
4.4. Social/Interpersonal Relationships. OCD can have a
considerable impact on social or interpersonal relationships
and this domain is assessed by the social functioning domain
in the SF-36 and personal relationships domain in the
DLQI. The SF-36 assesses this domain by inquiring about
the frequency and extent of interference with normal social
activities such as visiting friends and relatives. Although this
domain score was signiﬁcantly lower than population norms
in two studies [33, 38], OCD was not shown to havean eﬀect
in interpersonal relationships in one study [39].
Conversely, the DLQI identiﬁes the eﬀect of OCD on
sexual diﬃculties and problems with partners, close friends,
or relatives, and three of the reviewed studies found no
or little eﬀe c to nt h i sd o m a i n[ 29, 33, 39]. Some studies
reported the proportion instead of domain scores and in
these studies, the percentage of OCD patient aﬀected by
OCD on their interpersonal relationships ranged from 19
to 44% [30, 32, 35]. Other studies also found that those
with occupational ACD were concerned about interacting
with coworkers because of the skin disease [31], while
18.6% reported diﬃculty in family relationships, includ-
ing rejection by a spouse and in some cases, divorce
[35].
4.5. Eﬀects on Gender, Age, and Disease Severity. Af e w
studies have found that the eﬀect of OCD on QoL varied
between males and females. Severalstudies reported a higher
impact of OCD on QoL in females [33, 37], while others
reported similar eﬀects in men and women [29, 36, 39].
The apparent greater eﬀect in females may be explained by
a higher prevalence of health seeking behaviour by females
in general [42], or a larger eﬀect on the mental and social
Q o Ld o m a i ni nf e m a l e s[ 29, 34, 38]. Some studies detected a
sex diﬀerence in QoL using a generic measure [33, 37]w h i l e
other studies detected a diﬀerence when a dermatology-
speciﬁc instrument was used [38].
Increasing age had been found by one study to increase
the impact of OCD on QoL [37] but this was contradicted
by three other studies [29, 33, 36] that found no signiﬁcant
association between age and QoL in patients with OCD.
In a Swedish study, a signiﬁcant interaction between both
total PCS and the physical function domain of SF-36 and
age was found in females but not males [33]. In a previous
paper, the association between age and OCD disappeared
when occupation was taken into account in the analysis [2];
therefore, it seemed that age was unlikely to have a major
inﬂuence on QoL in OCD patients.
Of the includedstudies, ﬁve assessed the severity of OCD
[35–39]. A high degree of disease severity was generally
associated with a low QoL [36, 38, 39]. No signiﬁcant
correlation was found between severity of skin disease and
QoL as determined by SF-36 in two studies [37, 39]. In
contrast, when a dermatology-speciﬁc instrument was used,
signiﬁcant correlations between OCD severity and QoL
were reported [36, 37, 39]. However, the assessment of
the severity of skin disease has been challenging and was
not consistent across studies. Some assessments were based
on more objective criteria such as morphology, extent of
dermatitis, and frequency of ﬂare-up [35, 36, 39], while
others used a simple subjective description to determine
severity [38, 39].
4.6. Prognosis. Several studies reassessed the participants on
followup. The improvement rate varied widely from as little
as21%toasmuchas65%[34,37,39].Someparticipantshad
developed persistent postoccupational dermatitis (PPOD)
[43]w h e nr evi e w e d[ 35, 39]. PPOD has been associated with
a reduced ability to work, a negative impact on a ﬁnancial
situation or interference with personal life [44, 45].
5.Discussion
OCD-related QoL was found to be reduced in all studies
with the areas of highest impact being eﬀects on work and
symptoms/feelings. Nevertheless, a large variation between
studies was observed in design, patient recruitment, par-
ticipants’ characteristics, assessment of disease severity, and
QoL instruments used. This variation in methodology across
studies makes comparisons between studies somewhat diﬃ-
cult. Another diﬃculty in epidemiological studies of OCD
is the lack of a clear and standardised deﬁnition of OCD.
The deﬁnitions of OCD used in the reviewed studies have
been inconsistent. OCD is not a homogeneous condition: it10 Journal of Allergy
may be ICD or ACD or contact urticaria [2]. Apart from
the criteria provided by Mathias in 1989 [46], no other
studies had provided a deﬁnition for OCD. Our group has
previously referred to the lack of standardisation of OCD
[4].
The current paper raises several issues to be considered
in future research. We found that several studies used
both generic and dermatology-speciﬁc questionnaires to
assess QOL. The main advantage of this is to fully capture
the eﬀect of OCD on QOL. Given OCD inﬂuences so
many diﬀerent areas of lifestyle, health, economic burden,
emotions, and feelings, it is unlikely that the use of either a
generic or dermatology-speciﬁc instrument will be entirely
adequate. To date, there is no validated QoL instrument
speciﬁc to OCD and the development of a simple yet
comprehensive QoL instrument speciﬁc to OCD would be
of considerable clinical beneﬁt. Currently an international
group is investigating the possibility of adding OCD-speciﬁc
questions to the DLQI and one of the coauthors (RN) of
this paper is currently part of a project that is piloting the
new questionnaire (personal communication, Dr P¨ aivikki
Susitaival).
One important area of research missing from the current
literature on QOL in OCD is the evaluation of QoL over
time. The assessment of QOL at baseline and then at
followup allows the change in physical symptoms and the
other components of QOL to be assessed in a validated,
consistent manner. Using QoL measures in routine clini-
cal settings will provide patients with an opportunity to
express their concerns and assist clinicians in evaluating the
eﬀectiveness of management beyond the clinical outcomes.
Among the studies included in this paper, only two [32, 36]
evaluated QoL over time and found an improvement in
QOL.
Data on the impact of disease severity on QoL is limited
and even the existing literature has assessed disease severity
inconsistently across studies, if at all. Furthermore, both
objective and subjective measures have been used to evaluate
disease severity making interpretation and comparison even
more diﬃcult. OCD is primarily a disease of the hands
and the existing and validated measures of disease severity
[47, 48] rely heavily on body surface involvement. Severity
scales have been developed for use by the physician in
the assessment of hand eczema [49–51] and one has been
developed by our group speciﬁcally to assess functional
l i m i t a t i o n sa sw e l la ss e v e r i t yi nO C D[ 52, 53]. Using these
objective measures of severity in future research would allow
for direct comparisons across studies in diﬀerent countries
and occupational groups.
In conclusion, this paper has shown that OCD has a
heavy impact on QOL, particularly on work arrangements,
which can have important ﬁnancial and social conse-
quences if not addressed adequately. We would highlight
the opportunity for more routine use of QoL measures in
patient management. Further studies would beneﬁt from
using multiple validated instruments to assess both QOL
and disease severity, and speciﬁcally a comprehensive QoL
instrumentspeciﬁctoOCD,whichwouldenablecomparison
across countries and occupational groups.
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